David Watumull - Cardax Insider

Cardax Inc -- USA Stock  

USD 0.19  0.0001  0.0526%

VP of Operations, Assistant Treasurer and Assistant Secretary

Mr. David M. Watumull is Chief Operating Officer, Assistant Treasurer, Assistant Secretary of the Cardax, Inc. Mr. Watumull has served as Vice President, Operations of Pharma since its inception in May 2013, Assistant Treasurer and Assistant Secretary of Pharma since July 2013, and Secretary and Treasurer of Pharma from its inception in May 2013 to July 2013. Mr. Watumull has served as Vice President, Operations, Assistant Treasurer, and Assistant Secretary of Holdings since July 2013, and previously as Director, Operations and Finance from 2009 to 2013, Operations Manager from 2008 to 2009, and Program Manager from its inception in 2006 to 2009. Mr. Watumull heads daytoday company operations related to accounting, banking, budgeting, leasing, insurance, debtequity transactions and due diligence, capitalization structure, reporting, corporate governance, contracting and related legal matters, intellectual property, human resources, front office, facilities and equipment, and information technology. Mr. Watumull also manages the relationships, timelines, and budgets of development partners, contractors, and regulatory consultants associated with the production and testing of Cardax products. Mr. Watumull was previously Program Manager at Hawaii Biotech, Inc. from 2005 to 2006, Project Coordinator from 2004 to 2005, and Information Technology Associate Manager from 2002 to 2004. Mr. Watumull also worked at Aquasearch, Inc. from 2000 to 2001 in various capacities including Medical Information Specialist and Information Technology Associate. Mr. Watumull graduated first in his high school class and studied Electrical Engineering at the University of Hawaii
Age: 34  VP Since 2017      
808-457-1400  http://www.cardaxpharma.com
Watumull was Executive Vice President of Aquasearch, Inc., a public astaxanthin consumer health company, from 1998 to 2000. From 1997 to 1998 he headed his own biotech research firm, Watumull & Co. From 1994 to 1997 he was a biotech research analyst, money manager, and investment banker at First Honolulu Securities. From 1992 to 1994 he led his own money management firm, Biovest, Inc. Prior to that, from 1982 to 1992, Mr. Watumull worked at Paine Webber in various capacities, including as a biotech money manager and investment executive.

Management Efficiency

The company has return on total asset (ROA) of (43.62) % which means that it has lost $43.62 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (12.0) % meaning that it created substantial loss on money invested by shareholders.

Entity Summary

Cardax, Inc., a life sciences company, focuses on developing consumer health and pharmaceutical technologies for solutions that would provide the antiinflammatory benefits of steroids or nonsteroidal antiinflammatory drugs. Cardax Inc (CDXI) is traded on OTC Market in USA. It is located in HAWAII, U.S.A and employs 9 people. Cardax is listed under Restaurants Hotels Motels category by Fama And French industry classification.

Did you try this?

Run Portfolio Backtesting Now

Portfolio Backtesting

Avoid under-diversification and over-optimization by backtesting your portfolios
Hide  View All  NextLaunch Portfolio Backtesting
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Cardax Inc to your portfolio

Top Management

Cardax Inc Leadership Team
George Bickerstaff, Director
Nicholas Mitsakos, Chairman
Richard Morris, Executive
Tamar Howson, Director, MBA
Gilbert Shin, President
Frank Herringer, Director, MBA
Terence Kelly, Director
David Watumull, VP
Michele Galen, Director
John Russell, CFO, CPA

Stock Performance

Cardax Performance Indicators